With the analysis among 1,164 patents, we discovered top 104 key players by total patent application. Genzyme Corp., Shire Human Genetic Therapies, Inc., BioMarin Pharmaceutical, Inc. are dominant in this area. They take 45.27% of the total patent filing.
Massachusetts, United States
Patent: 271
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 146
BioMarin Pharmaceutical, Inc.
California, United States
Patent: 110
Sangamo Therapeutics, Inc.
California, United States
Patent: 40
Amicus Therapeutics, Inc.
New Jersey, United States
Patent: 37
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 36
Alexion Pharmaceuticals, Inc.
Connecticut, United States
Patent: 19
biOasis Technologies, Inc.
Connecticut, United States
Patent: 19
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 16
With the analysis among 40 patents, we discovered top 7 start-ups by total patent application. Prevail Therapeutics, Inc., Remix Therapeutics, Inc., IntraBio Ltd. are active in this area.
Prevail Therapeutics, Inc.
New York, United States
Patent: 13
Massachusetts, United States
Patent: 8
Nordrhein-Westfalen, Germany
Patent: 6
Institut National de la Santé et de la Recherche Médicale
Nacuity Pharmaceuticals, Inc.
Texas, United States
Patent: 2
With the analysis among related 416 patents applied in the last 5 years. We discover 97 most active companies in this area. The fast-growing Genzyme Corp., Shire Human Genetic Therapies, Inc., Regeneron Pharmaceuticals, Inc. take 23.32% of patent filing during this period.
Massachusetts, United States
Patent: 50
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 26
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 21
Sangamo Therapeutics, Inc.
California, United States
Patent: 14
Prevail Therapeutics, Inc.
New York, United States
Patent: 13
BioMarin Pharmaceutical, Inc.
California, United States
Patent: 13
Rush University Medical Center
Illinois, United States
Patent: 11
The Children's Hospital of Philadelphia
Pennsylvania, United States
Patent: 10
Georgetown University School of Medicine
District of Columbia, United States
Patent: 10
Norbet Pharmaceutical Technology (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 9
With the analysis among related 416 patents in last 5 years, we discover 60 new entrants. Prevail Therapeutics, Inc., The Children's Hospital of Philadelphia, Georgetown University School of Medicine are the most active new entrants in this area.
Prevail Therapeutics, Inc.
New York, United States
Patent: 13
The Children's Hospital of Philadelphia
Pennsylvania, United States
Patent: 10
Georgetown University School of Medicine
District of Columbia, United States
Patent: 10
Norbet Pharmaceutical Technology (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 9
Massachusetts, United States
Patent: 8
Tokushima-ken, Japan
Patent: 7
Nordrhein-Westfalen, Germany
Patent: 6
University of Utah Research Foundation
Utah, United States
Patent: 6
Kyoto Prefectural Public University Corp.
With the analysis among 196 patents, we discovered top 46 universities and scientific research institutions by total patent application. St. Louis University, The Scripps Research Institute, Baylor College of Medicine are dominant in this area. They take 20.92% of the total patent filing.
Missouri, United States
Patent: 14
The Scripps Research Institute
California, United States
Patent: 10
Baylor College of Medicine
Texas, United States
Patent: 10
Georgetown University School of Medicine
District of Columbia, United States
Patent: 10
New York, United States
Patent: 9
North Carolina, United States
Patent: 7
Tokushima-ken, Japan
Patent: 7
Minnesota, United States
Patent: 5
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 5